NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/20/2026
Back to search
Official data from USPTO
Q-VANT BIOSCIENCES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
Q-VANT BIOSCIENCES
ST13
US500000099061584Class
5
Filing
99061584
Registration
8107012
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
01/20/2026
Trademark type
Word
Nice classes
5
Filing date
02/28/2025
Registration date
01/20/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/20/2026
Last transaction
01/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
12/13/2022
First use in commerce
03/15/2023
Drawing code
4
Owner type
03
Owner location
Forestdale, MA
Examiner
TORPEY, KATHERINE ANN
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Q-VANT Biosciences, Inc.
Representatives
Q-VANT Biosciences, Inc.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccine adjuvants; Adjuvants for use with vaccines; Adjuvants for medical purposes; Herbal supplements; Oral vaccine preparations; Adjuvants for veterinary purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Plant and herb extractsother than essential oilsfor medicinal purposes; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Human vaccine preparations; Herbal extractsother than essential oilsfor medical purposes; Adjuvants for veterinary use; Veterinary vaccines
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/20/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/02/2025
PUBO
PUBLISHED FOR OPPOSITION
12/02/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/26/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/30/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/30/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/29/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/29/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/22/2025
GNFR
FINAL REFUSAL E-MAILED
09/22/2025
CNFR
FINAL REFUSAL WRITTEN
09/22/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/26/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/26/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/26/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/04/2025
GNRT
NON-FINAL ACTION E-MAILED
08/04/2025
CNRT
NON-FINAL ACTION WRITTEN
08/04/2025
DOCK
ASSIGNED TO EXAMINER
08/04/2025
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
03/03/2025
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
03/03/2025
MAFR
APPLICATION FILING RECEIPT MAILED
02/28/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/28/2025
NWAP
NEW APPLICATION ENTERED
02/28/2025
Continuous trademark protection
Get notified about every new filing that threatens Q-VANT BIOSCIENCES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.